Virus-like particles (VLPs) are virus-derived structures made up of one or more different
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …

Self-assembled peptides and proteins possess tremendous potential as targeted drug
delivery systems and key applications of these well-defined nanostructures reside in anti …

Human papillomavirus (HPV) infection is the cause of a growing percentage of head and
neck cancers (HNC); primarily, a subset of oral squamous cell carcinoma, oropharyngeal …

Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

Bacteriophages, or phages, are viruses that specifically infect bacteria and coopt the cellular
machinery to create more phage proteins, eventually resulting in the release of new phage …

A novel coronavirus (SARS-CoV-2) emerged from China in late 2019 and rapidly spread
across the globe, infecting millions of people and generating societal disruption on a level …

Subunit vaccines containing one or more target antigens from pathogenic organisms
represent safer alternatives to whole pathogen vaccines. However, the antigens by …

Vaccines represent one of the most successful public health initiatives worldwide. However,
despite the vast number of highly effective vaccines, some infectious diseases still do not …

In recent decades, the development of plant virology and genetic engineering techniques
has resulted in the construction of plant virus-based vaccines for protection against different …

Peptide vaccines have shown great potential in cancer immunotherapy by targeting tumor
antigens and activating the patient's immune system to mount a specific response against …